{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:53:08Z","timestamp":1789519988371,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/nrcardio.2012.10","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T09:25:28Z","timestamp":1329211528000},"page":"234-242","source":"Crossref","is-referenced-by-count":33,"title":["Sex-related differences in patients' responses to heart failure therapy"],"prefix":"10.1038","volume":"9","author":[{"given":"Alon","family":"Barsheshet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brenyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"key":"BFnrcardio201210_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","volume":"123","author":"VL Roger","year":"2011","unstructured":"Roger, V. L.  et al. Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association. Circulation 123, e18\u2013e209 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR2","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"K Dickstein","year":"2008","unstructured":"Dickstein, K.  et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29, 2388\u20132442 (2008).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201210_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jama.292.3.344","volume":"292","author":"VL Roger","year":"2004","unstructured":"Roger, V. L.  et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292, 344\u2013350 (2004).","journal-title":"JAMA"},{"key":"BFnrcardio201210_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa020265","volume":"347","author":"D Levy","year":"2002","unstructured":"Levy, D.  et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397\u20131402 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.amjcard.2007.12.035","volume":"101","author":"A Barsheshet","year":"2008","unstructured":"Barsheshet, A.  et al. Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am. J. Cardiol. 101, 1303\u20131308 (2008).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201210_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield, M. M.  et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289, 194\u2013202 (2003).","journal-title":"JAMA"},{"key":"BFnrcardio201210_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy, D., Larson, M. G., Vasan, R. S., Kannel, W. B. & Ho, K. K. The progression from hypertension to congestive heart failure. JAMA 275, 1557\u20131562 (1996).","journal-title":"JAMA"},{"key":"BFnrcardio201210_CR8","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1161\/01.CIR.99.14.1816","volume":"99","author":"KF Adams Jr.","year":"1999","unstructured":"Adams, K. F. Jr.  et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99, 1816\u20131821 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR9","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/01.CIR.0000012546.20194.33","volume":"105","author":"JK Ghali","year":"2002","unstructured":"Ghali, J. K., Pina, I. L., Gottlieb, S. S., Deedwania, P. C. & Wikstrand, J. C. Metoprolol CR\/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 105, 1585\u20131591 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/0002-9149(93)90355-G","volume":"72","author":"R De Maria","year":"1993","unstructured":"De Maria, R.  et al. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC). Am. J. Cardiol. 72, 580\u2013585 (1993).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201210_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/01.CIR.103.3.375","volume":"103","author":"T Simon","year":"2001","unstructured":"Simon, T., Mary-Krause, M., Funck-Brentano, C. & Jaillon, P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 103, 375\u2013380 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR12","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.jacc.2003.05.012","volume":"42","author":"JK Ghali","year":"2003","unstructured":"Ghali, J. K.  et al. Gender differences in advanced heart failure: insights from the BEST study. J. Am. Coll. Cardiol. 42, 2128\u20132134 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/S0735-1097(96)00380-4","volume":"28","author":"KF Adams Jr.","year":"1996","unstructured":"Adams, K. F. Jr.  et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J. Am. Coll. Cardiol. 28, 1781\u20131788 (1996).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.mcna.2004.03.003","volume":"88","author":"LH Lund","year":"2004","unstructured":"Lund, L. H. & Mancini, D. Heart failure in women. Med. Clin. North Am. 88, 1321\u20131345 (2004).","journal-title":"Med. Clin. North Am."},{"key":"BFnrcardio201210_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jacc.2009.02.066","volume":"54","author":"EM Hsich","year":"2009","unstructured":"Hsich, E. M. & Pina, I. L. Heart failure in women: a need for prospective data. J. Am. Coll. Cardiol. 54, 491\u2013498 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR16","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.106.672006","volume":"116","author":"JP Konhilas","year":"2007","unstructured":"Konhilas, J. P. & Leinwand, L. A. The effects of biological sex and diet on the development of heart failure. Circulation 116, 2747\u20132759 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR17","doi-asserted-by":"publisher","first-page":"H2544","DOI":"10.1152\/ajpheart.00338.2002","volume":"283","author":"M Jain","year":"2002","unstructured":"Jain, M.  et al. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 283, H2544\u2013H2550 (2002).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201210_CR18","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.lfs.2004.04.024","volume":"75","author":"MA Cavasin","year":"2004","unstructured":"Cavasin, M. A., Tao, Z., Menon, S. & Yang, X. P. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci. 75, 2181\u20132192 (2004).","journal-title":"Life Sci."},{"key":"BFnrcardio201210_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0735-1097(98)00400-8","volume":"32","author":"F Follath","year":"1998","unstructured":"Follath, F., Cleland, J. G., Klein, W. & Murphy, R. Etiology and response to drug treatment in heart failure. J. Am. Coll. Cardiol. 32, 1167\u20131172 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/0002-8703(93)90414-5","volume":"126","author":"B Andersson","year":"1993","unstructured":"Andersson, B. & Waagstein, F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am. Heart J. 126, 632\u2013640 (1993).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201210_CR21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","volume":"30","author":"BA Bart","year":"1997","unstructured":"Bart, B. A.  et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 30, 1002\u20131008 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","volume":"39","author":"GM Felker","year":"2002","unstructured":"Felker, G. M., Shaw, L. K. & O'Connor, C. M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J. Am. Coll. Cardiol. 39, 210\u2013218 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR23","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/eurheartj\/ehq407","volume":"32","author":"A Barsheshet","year":"2011","unstructured":"Barsheshet, A.  et al. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur. Heart J. 32, 1622\u20131630 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201210_CR24","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan, R. S.  et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol. 33, 1948\u20131955 (1999).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0735-1097(02)02696-7","volume":"41","author":"FA Masoudi","year":"2003","unstructured":"Masoudi, F. A.  et al. Gender, age, and heart failure with preserved left ventricular systolic function. J. Am. Coll. Cardiol. 41, 217\u2013223 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1161\/01.CIR.90.2.786","volume":"90","author":"DM Gilligan","year":"1994","unstructured":"Gilligan, D. M., Badar, D. M., Panza, J. A., Quyyumi, A. A. & Cannon, R. O. 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation 90, 786\u2013791 (1994).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR27","first-page":"3384","volume":"80","author":"O Ylikorkala","year":"1995","unstructured":"Ylikorkala, O., Orpana, A., Puolakka, J., Pyorala, T. & Viinikka, L. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J. Clin. Endocrinol. Metab. 80, 3384\u20133387 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrcardio201210_CR28","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/hq0901.095565","volume":"21","author":"A Saitta","year":"2001","unstructured":"Saitta, A.  et al. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 21, 1512\u20131519 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201210_CR29","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/01.HYP.8.11.1044","volume":"8","author":"S Landahl","year":"1986","unstructured":"Landahl, S., Bengtsson, C., Sigurdsson, J. A., Svanborg, A. & Sv\u00e4rdsudd, K. Age-related changes in blood pressure. Hypertension 8, 1044\u20131049 (1986).","journal-title":"Hypertension"},{"key":"BFnrcardio201210_CR30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/01.CIR.91.7.1952","volume":"91","author":"OC Gebara","year":"1995","unstructured":"Gebara, O. C.  et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 91, 1952\u20131958 (1995).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR31","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer, M.  et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U. S. Carvedilol Heart Failure Study Group. N. Engl. J. Med. 334, 1349\u20131355 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR32","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer, M.  et al. Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. 344, 1651\u20131658 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"SA Hunt","year":"2009","unstructured":"Hunt, S. A.  et al. 2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 53, e1\u2013e90 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR34","doi-asserted-by":"crossref","unstructured":"[No authors listed] Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N. Engl. J. Med. 316, 1429\u20131435 (1987).","DOI":"10.1056\/NEJM198706043162301"},{"key":"BFnrcardio201210_CR35","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg, R. & Yusuf, S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273, 1450\u20131456 (1995).","journal-title":"JAMA"},{"key":"BFnrcardio201210_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","volume":"41","author":"PG Shekelle","year":"2003","unstructured":"Shekelle, P. G.  et al. Efficacy of angiotensin-converting enzyme inhibitors and \u03b2-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J. Am. Coll. Cardiol. 41, 1529\u20131538 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR37","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","volume":"110","author":"JB Young","year":"2004","unstructured":"Young, J. B.  et al. Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation 110, 2618\u20132626 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR38","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"JN Cohn","year":"2001","unstructured":"Cohn, J. N. & Tognoni, G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345, 1667\u20131675 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt, B.  et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709\u2013717 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR40","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt, B.  et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309\u20131321 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad, F.  et al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. 364, 11\u201321 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR42","doi-asserted-by":"crossref","unstructured":"The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 336, 525\u2013533 (1997).","DOI":"10.1056\/NEJM199702203360801"},{"key":"BFnrcardio201210_CR43","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa021266","volume":"347","author":"SS Rathore","year":"2002","unstructured":"Rathore, S. S., Wang, Y. & Krumholz, H. M. Sex-based differences in the effect of digoxin for the treatment of heart failure. N. Engl. J. Med. 347, 1403\u20131411 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR44","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"AJ Moss","year":"1996","unstructured":"Moss, A. J.  et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med. 335, 1933\u20131940 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR45","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton, A. E.  et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 341, 1882\u20131890 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss, A. J.  et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877\u2013883 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR47","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa033088","volume":"350","author":"A Kadish","year":"2004","unstructured":"Kadish, A.  et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med. 350, 2151\u20132158 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy, G. H.  et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225\u2013237 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR49","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1540-8167.2005.00224.x","volume":"16","author":"W Zareba","year":"2005","unstructured":"Zareba, W.  et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J. Cardiovasc. Electrophysiol. 16, 1265\u20131270 (2005).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201210_CR50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/archinternmed.2009.255","volume":"169","author":"H Ghanbari","year":"2009","unstructured":"Ghanbari, H.  et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 169, 1500\u20131506 (2009).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201210_CR51","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.hrthm.2010.03.042","volume":"7","author":"P Santangeli","year":"2010","unstructured":"Santangeli, P.  et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 7, 876\u2013882 (2010).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201210_CR52","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow, M. R.  et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140\u20132150 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR53","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland, J. G.  et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352, 1539\u20131549 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR54","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","volume":"117","author":"ES Chung","year":"2008","unstructured":"Chung, E. S.  et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 117, 2608\u20132616 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR55","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"Moss, A. J.  et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361, 1329\u20131338 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR56","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.108.818724","volume":"120","author":"M St. John Sutton","year":"2009","unstructured":"St. John Sutton, M.  et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I\/II heart failure. Circulation 120, 1858\u20131865 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR57","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","volume":"363","author":"AS Tang","year":"2010","unstructured":"Tang, A. S.  et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363, 2385\u20132395 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201210_CR58","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jacc.2010.06.061","volume":"57","author":"A Arshad","year":"2011","unstructured":"Arshad, A.  et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J. Am. Coll. Cardiol. 57, 813\u2013820 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR59","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.jacc.2009.08.011","volume":"54","author":"C Daubert","year":"2009","unstructured":"Daubert, C.  et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J. Am. Coll. Cardiol. 54, 1837\u20131846 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.amjcard.2008.08.069","volume":"103","author":"EC Adelstein","year":"2009","unstructured":"Adelstein, E. C. & Saba, S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am. J. Cardiol. 103, 238\u2013242 (2009).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201210_CR61","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","volume":"123","author":"W Zareba","year":"2011","unstructured":"Zareba, W.  et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 123, 1061\u20131072 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR62","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.amjcard.2008.11.008","volume":"103","author":"NA Marsan","year":"2009","unstructured":"Marsan, N. A.  et al. Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy. Am. J. Cardiol. 103, 690\u2013694 (2009).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201210_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/eurheartj\/ehn577","volume":"30","author":"G Wikstrom","year":"2009","unstructured":"Wikstrom, G.  et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur. Heart J. 30, 782\u2013788 (2009).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201210_CR64","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.104.520817","volume":"113","author":"MG St. John Sutton","year":"2006","unstructured":"St. John Sutton, M. G.  et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113, 266\u2013272 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR65","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/01.CIR.0000095027.28753.9D","volume":"108","author":"RS Crow","year":"2003","unstructured":"Crow, R. S., Hannan, P. J. & Folsom, A. R. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC study with 13 years of follow-up. Circulation 108, 1985\u20131989 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR66","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina, S. & Abel, E. D. Diabetic cardiomyopathy revisited. Circulation 115, 3213\u20133223 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio201210_CR67","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"SA Hunt","year":"2005","unstructured":"Hunt, S. A.  et al. ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 46, e1\u2013e82 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201210_CR68","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","volume":"346","author":"WT Abraham","year":"2002","unstructured":"Abraham, W. T.  et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346, 1845\u20131853 (2002).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2012.10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2012.10","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2012.10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:49:17Z","timestamp":1684468157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2012.10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFnrcardio201210"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2012.10","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]}}}